The application axis of Veterinary Dietary Supplements segmentation classifies products by the clinical condition they aim to support, a framework essential for demand forecasting and portfolio prioritization. Joint health supplements, centered on glucosamine, chondroitin, and MSM, dominate the landscape, reflecting the high prevalence of osteoarthritis in companion animals and accounting for approximately 30 % of market share. Digestive health formulations—primarily probiotics, prebiotics, and fiber blends—address dysbiosis and nutrient absorption issues, contributing 25 % of revenues. Immune support products, which combine vitamins, minerals, and botanical antioxidants, respond to growing preventive‑care trends and represent 20 % of the market. Skin & coat supplements, rich in omega‑3 fatty acids and biotin, are driven by aesthetic and dermatological concerns, delivering 15 % of sales. Cardiovascular supplements, focused on taurine, L‑carnitine, and omega‑3s, serve a niche but expanding segment, accounting for the remaining 10 %. This application‑focused taxonomy provides a granular view of how each therapeutic area contributes to the overall Veterinary Dietary Supplements market.